Insiders Appili Therapeutics Inc.

Equities

APLI

CA03783R1073

Market Closed - Toronto S.E. Other stock markets 12:59:22 2024-04-30 pm EDT			5-day change	1st Jan Change
0.035 ^CAD	-12.50%		-12.50%	-.--%

Apr. 26	Appili Therapeutics Inc. announced that it has received CAD 0.3 million in funding	CI
Apr. 02	Appili Therapeutics To be Acquired by Aditxt, Inc.	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Appili Therapeutics Inc. Appoints Prakash Gowd to its Board of Directors	Nov. 13	CI
Appili Therapeutics Q2 Net Loss and Comprehensive Loss Narrows Vs a Year Ago	Nov. 13	MT
Appili Therapeutics Inc. Announces Demise of Rochelle Stenzler, as the Director of the Company	23-10-25	CI
Appili Therapeutics Inc. Appoints Gary Nabors as Chief Development Officer	23-04-03	CI
Appili Therapeutics Appoints Dr. Carl Gelhaus and Arthur Baran to Support ATI-1701 Biodefense Vaccine Program	23-01-17	MT
Appili Therapeutics Inc. Announces Executive Appointments	23-01-17	CI
Appili Therapeutics Inc. Announces Management Changes	22-11-14	CI
Appili Therapeutics Inc. Promotes Don Cilla to the Position of Chief Executive Officer	22-11-14	CI
Appili Details "Positive" One Year Challenge Results from Preclinical Study Evaluating Biodefense Vaccine Candidate, Change to Board of Directors	21-11-19	MT
Appili Therapeutics Inc. Announces Resignation of Josef Vejvoda from the Board of Directors	21-11-19	CI
Appili Therapeutics Inc. Appoints Josef Vejvoda to Its Board of Directors	21-09-08	CI
Appili Therapeutics Inc. Appoints Rochelle Stenzler as Board of Directors	21-02-02	CI
Appili Therapeutics Inc. Announces Appointment of Don Cilla as Chief Development Officer, Effective November 1, 2020	20-10-29	CI
Appili Therapeutics Inc. Appoints Yoav Golan, MD, to Serve as First Chief Medical Officer	20-04-21	CI
Appili Therapeutics Inc. Announces Board Changes	20-01-27	CI
Appili Therapeutics Inc. Announces Executive Changes	19-12-02	CI
Appili Therapeutics Inc. Appoints Theresa Matkovits to its Board of Directors	18-10-09	CI
Appili Therapeutics Inc. Appoints Armand Balboni as First Chief Scientific Officer	18-10-01	CI
Appili Therapeutics Appoints Seasoned Biotech Executive Ian C. Mortimer to its Board	17-11-28	CI
Appili Therapeutics Inc. Names Sean McBride as Vice President, Business Development	17-07-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Appili Therapeutics Inc.

Equities

APLI

CA03783R1073

Insiders

Filters